AxoGen Inc (AXGN) Q3 2019 Earnings Call Transcript
AXGN earnings call for the period ending September 30, 2019.
AxoGen
AXGN
AXGN
$16.09
-$0.58
-3.5%
BATS BZX Real Time Price as of December 9, 2019, 4:00 p.m. EST
View Interactive AXGN Charts
AxoGen Inc. is a regenerative medicine company with a portfolio of proprietary products and technologies for peripheral nerve reconstruction and regeneration.
News & Analysis: AxoGen
AxoGen Inc (AXGN) Q2 2019 Earnings Call Transcript
AXGN earnings call for the period ending June 30, 2019.
AxoGen Inc (AXGN) Q1 2019 Earnings Call Transcript
AXGN earnings call for the period ending March 31, 2019.
AxoGen Inc (AXGN) Q4 2018 Earnings Conference Call Transcript
AXGN earnings call for the period ending December 31, 2018.
Here's Why AxoGen Slipped Again Today
Investors wondering if they'll ever see a profit didn't get the outlook they wanted.
Here's Why AxoGen, Inc. Was Hammered Today
A scathing short-seller report started circulating at a bad time for the nerve repair specialist.
AxoGen (AXGN) Q3 2018 Earnings Conference Call Transcript
AXGN earnings call for the period ending September 30, 2018.
Here's Why AxoGen, Inc. Fell as Much as 18.6% Today
The healthcare company reported second-quarter 2018 earnings.
AxoGen (AXGN) Q4 2017 Earnings Conference Call Transcript
AXGN earnings call for the period ending December 31, 2017.
2 Biotech Stocks that Turned $8,000 into over $250,000
An $8,000 investment in these biotech stocks 10 years ago would be worth over $250,000 today. Are more gains ahead?
